News

It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.
According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced it ...
Brain metastasis is emerging as the most serious concern for breast cancer patients. HER2-positive breast cancer is more prone to undergo brain metastasis than other subtypes; notably, there has been ...
Michael Wolff was at the "edge of a cliff" when he was diagnosed with a cancer that affects less than 300 patients a year in ...
According to a new study published in BMC Cancer, “CBD demonstrated significant anticancer effects, including induction of ...
A new study published in the Asian Journal of Urology has found that certain cannabis strains rich in cannabinoids like CBC ...
Research indicates a link between Vitamin D levels and Colorectal cancer risk. Higher vitamin D may lower the risk. Calcitriol, the active form of vitamin D, slows cancer cell growth. It also promotes ...
Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...